Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1649
|
88
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.200 |
None |
1.000 |
1 |
|
1999 |
1999 |
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
22
|
22
|
0.100 |
None |
1.000 |
5 |
20
|
2008 |
2018 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1
|
disease |
|
Disease or Syndrome
|
3
|
7
|
0.100 |
None |
|
0 |
6
|
|
|
BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
3
|
3
|
0.100 |
None |
|
0 |
2
|
|
|
BASAL CELL CARCINOMA, SOMATIC
|
disease |
|
Neoplastic Process
|
5
|
7
|
0.100 |
None |
|
0 |
3
|
|
|
Mycoplasma Infections
|
group |
Infections
|
Disease or Syndrome
|
188
|
1
|
0.070 |
None |
1.000 |
7 |
|
2010 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.040 |
None |
1.000 |
4 |
|
2016 |
2019 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.030 |
None |
0.667 |
3 |
|
2007 |
2009 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.030 |
None |
0.667 |
3 |
|
2007 |
2009 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.030 |
None |
0.667 |
3 |
|
2007 |
2009 |
Lyme Disease
|
disease |
Infections
|
Disease or Syndrome
|
178
|
4
|
0.030 |
None |
1.000 |
3 |
|
1997 |
1999 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2016 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2007 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2016 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2007 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2014 |
Xeroderma Pigmentosum
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
137
|
35
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
0.500 |
2 |
|
1997 |
2007 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Erythema Chronicum Migrans
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
41
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |